Bio-Techne Corp (NAS:TECH)
$ 83.805 0.965 (1.16%) Market Cap: 13.21 Bil Enterprise Value: 13.40 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Stephens Investor Conference Transcript

Nov 13, 2019 / 03:45PM GMT
Release Date Price: $51.22 (+0.46%)
Jacob K. Johnson
Stephens Inc., Research Division - Analyst

All right. We'll go through my introduction, again. I'm Jacob Johnson, one of the healthcare analysts here at Stephens. Next up, joining us is Bio-Techne, a diversified life science tools company with a portfolio that includes reagents, instruments and services for research and clinical diagnostic markets worldwide. Joining us today are CFO, Jim Hippel; and Senior Director of IR and Corporate Development, Dave Clair. Thank you, guys, for joining us. Maybe to kick things off, Jim or Dave, if you just want to spend a couple of minutes running through the Bio-Techne story, and then we'll launch into Q&A.

James T. Hippel
Bio-Techne Corporation - Senior VP of Finance & CFO

Sure. I'll try to -- I'll do just it relatively briefly. Several in the room here, who I spoke to, know our story already. But our core is that we are a 40-year-old plus business that was one of the first companies, if not the first companies, to manufacture proteins for life science research. And in doing so over the last 40

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot